Latest Zofran Child Birth Defect Lawsuits
14 July 2015

Vermont Child Birth Defect Statistics & Zofran Lawsuits

Morning sickness can be unbearable and severe for some expecting mothers and can be dangerous to both the mother and the baby. Doctors have been prescribing Zofran to pregnant women to control their severe nausea and in most cases, it worked. However, recent studies have shown a link between Zofran usage and an increased risk of the child being born with a defect such as a cleft palate, congenital heart defects, and others. The drug was never approved by the FDA to treat morning sickness in pregnant women, it was originally manufactured and distributed for patients who were experiencing severe nausea because of radiation therapy treatments and those who are experieincg nausea due to various post-op procedures. For more information about the studies that link Zofran to child birth defects, visit our About Zofran page.

Because of the birth defects Zofran has been shown to cause, several lawsuits around the United States have been filed to hold the drug manuacturers and distributers responsible for the damage Zofran can cause to its users and their families.

Vermont: Child Birth Defect Statistics

The United States Centers for Disease Control (CDC) estimates that birth defects occur in one in every 33 live births. As of the 2010 U.S. Census, the population for the state of Vermont was 626,630, meaning that there is an estimated number of 344 children born with birth defects. In Vermont in particular, birth defects are the number one cause of death for infants under one year old. The Birth Information Network has collected data on more than 40 birth conditions in Vermont and one of the most documented cases is the defect of a cleft lip with or without a cleft palate.

Unfortunately, birth defects in children are all too common. The causes for birth defects can vary greatly from case to case, some causes being medical malpractice, genetic disorders, and defective drugs. Our team of Zofran lawyers has reviewed the data for Vermont and estimated the number of potential claims in the state. Our estimates are based off of the current studies on Zofran and birth defects, the population, and birth rates of Vermont.

Vermont’s Five Most Populous Cities Are:
Burlington – 42,417
South Burlington – 17,904
Colchester – 16,986
Rutland – 16,495
Essex Junction – 9,271

Estimated Number of Cases of Cleft Palate and Congenital Heart Defects in Vermont and It’s Major Cities

Vermont’s population at the time of the 2010 U.S. Census was 626,630 and by applying this number to the instance rate of birth defects that may have been linked to Zofran usage in the first trimester, we are able to estimate how many children in the state were born with these particular defects:

Orofacial Cleft (Cleft Palate/Cleft Lip) – 59
Congenital Heart Defects – 285

By applying this same formula to Vermont’s five most populous cities, we are able to estimate how many children in each city may have been born with these defects.

Burlington – 70 child birth defects
4 cleft lip and palate
66 congenital heart defects

South Burlington– 58 child birth defects
1 cleft lip and palate
57 congenital heart defects

Colchester– 58 child birth defects
2 cleft lip and palate
56 congenital heart defects

Rutland– 57 child birth defects
2 cleft lip and palate
55 congenital heart defects

Essex Junction– 54 child birth defects
1 cleft lip and palate
53 congenital heart defects

Birth Defects and Other Reported Side Effects

Despite the rising number of studies that are reporting links between Zofran usage in the first trimester and the increased risk of the child being born with birth defects, Glasko Smith Kline deines that Zofran is the cause of these defects. In the lawsuits that have been recently filed, Zofran victims allege that the drug caused the following in their children:
Atrial Septal Defect, Ventricular Septal Defect, Cleft Palate, Atrioventricular Septal Defect, Kidney Malformations
To further bolster these claims, the CDC and Sloan Epidemiology recently released a study that found a 2.37 times increased risk of a child being born with a cleft palate if the mother took Zofran during the first trimester of pregnancy.

Vermont Parents Working With ZofranLegal.com To File Zofran Lawsuits

ZofranLegal.com is created and sponsored by the law firms of Monheit Law, Janet Jenner & Suggs, Grant Eisenhofer, Markhoff & Mittman, and Banville Law for the sole purpose of providing timely information about current Zofran litigation. Our lawyers are not licensed to practice law in the state of Vermont but they are liscensed to practice law in Delaware, the state where Zofran’s manufacturere has its headquarters. Because of this, we are able to represent your family’s legal rights in a lawsuit that is filed in Delaware. For more on our Delaware team of Zofran lawyers, click here.

Depending on the circumstances of your personal case, it may be recommended that you file your case against Zofran in your home state of Vermont. Because of our work on Zofran cases, we have developed excellent working relationships with lawyers in Vermont who are more than capable of handling your Zofran litigation. To discuss these specifics of your case, contact us for a free case evaluation and consultation. Our Zofran team is available to speak with you 24/7.

Resources In Vermont for Children With Cleft Palate or Congenital Heart Birth Defects

Vermont Department of Health: Cleft Lip & Palate Clinic

University of Vermont Medical Center

Cleft Advocate

Department of Health

American Heart Society